Patents by Inventor Fengping XIAO

Fengping XIAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof
    Patent number: 11919918
    Abstract: A P2X3 and/or P2X2/3 receptor antagonist of formula (I), a pharmaceutical composition comprising the same, and a use thereof in preparing a drug for preventing or treating a disease mediated by the P2X3 and/or P2X2/3 receptor antagonist.
    Type: Grant
    Filed: May 27, 2022
    Date of Patent: March 5, 2024
    Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
    Inventors: Yanping Zhao, Hongjun Wang, Gong Li, Xiang Li, Yuanyuan Jiang, Kai Liu, Yeming Wang, Liying Zhou, Yanan Liu, Ning Shao, Fengping Xiao
  • Receptor inhibitors, pharmaceutical compositions comprising the same and use thereof
    Patent number: 11905274
    Abstract: The present invention discloses a receptor inhibitor of formula (I), a composition comprising the same and the usage thereof.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: February 20, 2024
    Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
    Inventors: Yanping Zhao, Hongjun Wang, Gong Li, Xiang Li, Yuanyuan Jiang, Yeming Wang, Huai Huang, Liying Zhou, Yanan Liu, Ning Shao, Fengping Xiao, Zhenguang Zou
  • RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF
    Publication number: 20230106958
    Abstract: The present invention discloses a receptor inhibitor of formula (I), a pharmaceutical composition comprising the same and the use thereof.
    Type: Application
    Filed: May 25, 2022
    Publication date: April 6, 2023
    Inventors: Yanping ZHAO, Hongjun WANG, Yeming WANG, Xiang LI, Yuanyuan JIANG, Huai HUANG, Fajie LI, Liying ZHOU, Ning SHAO, Fengping XIAO, Zhenguang ZOU
  • P2X3 AND/OR P2X2/3 RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF
    Publication number: 20220389039
    Abstract: A P2X3 and/or P2X2/3 receptor antagonist of formula (I), a pharmaceutical composition comprising the same, and a use thereof in preparing a drug for preventing or treating a disease mediated by the P2X3 and/or P2X2/3 receptor antagonist.
    Type: Application
    Filed: May 27, 2022
    Publication date: December 8, 2022
    Inventors: Yanping ZHAO, Hongjun WANG, Gong LI, Xiang LI, Yuanyuan JIANG, Kai LIU, Yeming WANG, Liying ZHOU, Yanan LIU, Ning SHAO, Fengping XIAO
  • Receptor inhibitor, pharmaceutical composition comprising same, and use thereof
    Patent number: 11453690
    Abstract: The present invention discloses a receptor inhibitor of formula (I), a pharmaceutical composition comprising the same and the use thereof.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: September 27, 2022
    Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
    Inventors: Yanping Zhao, Hongjun Wang, Yeming Wang, Xiang Li, Yuanyuan Jiang, Huai Huang, Fajie Li, Liying Zhou, Ning Shao, Fengping Xiao, Zhenguang Zou
  • P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof
    Patent number: 11414444
    Abstract: A P2X3 and/or P2X2/3 receptor antagonist of formula (I), a pharmaceutical composition comprising the same, and a use thereof in preparing a drag for preventing or treating a disease mediated by the P2X3 and/or P2X2/3 receptor antagonist.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: August 16, 2022
    Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
    Inventors: Yanping Zhao, Hongjun Wang, Gong Li, Xiang Li, Yuanyuan Jiang, Kai Liu, Yeming Wang, Liying Zhou, Yanan Liu, Ning Shao, Fengping Xiao
  • RECEPTOR INHIBITORS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND USE THEREOF
    Publication number: 20210395231
    Abstract: The present invention discloses a receptor inhibitor of formula (I), a composition comprising the same and the usage thereof.
    Type: Application
    Filed: February 22, 2019
    Publication date: December 23, 2021
    Inventors: Yanping ZHAO, Hongjun WANG, Gong LI, Xiang LI, Yuanyuan JIANG, Yeming WANG, Huai HUANG, Liying ZHOU, Yanan LIU, Ning SHAO, Fengping XIAO, Zhenguang ZOU
  • P2X3 AND/OR P2X2/3 RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF
    Publication number: 20210179648
    Abstract: A P2X3 and/or P2X2/3 receptor antagonist of formula (I), a pharmaceutical composition comprising the same, and a use thereof in preparing a drag for preventing or treating a disease mediated by the P2X3 and/or P2X2/3 receptor antagonist.
    Type: Application
    Filed: October 31, 2018
    Publication date: June 17, 2021
    Inventors: Yanping ZHAO, Hongjun WANG, Gong LI, Xiang LI, Yuanyuan JIANG, Kai LIU, Yeming WANG, Liying ZHOU, Yanan LIU, Ning SHAO, Fengping XIAO
  • RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF
    Publication number: 20210054007
    Abstract: The present invention discloses a receptor inhibitor of formula (I), a pharmaceutical composition comprising the same and the use thereof.
    Type: Application
    Filed: March 22, 2019
    Publication date: February 25, 2021
    Inventors: Yanping ZHAO, Hongjun WANG, Yeming WANG, Xiang LI, Yuanyuan JIANG, Huai HUANG, Fajie LI, Liying ZHOU, Ning SHAO, Fengping XIAO, Zhenguang ZOU